These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Adrenomedullin: Not Just Another Gastrointestinal Peptide. Martínez-Herrero S; Martínez A Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204657 [TBL] [Abstract][Full Text] [Related]
50. Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy. Vázquez R; Riveiro ME; Berenguer-Daizé C; O'Kane A; Gormley J; Touzelet O; Rezai K; Bekradda M; Ouafik L Front Oncol; 2020; 10():589218. PubMed ID: 33489885 [TBL] [Abstract][Full Text] [Related]
51. Immuno-modulatory effect of local rhEGF treatment during tissue repair in diabetic ulcers. García-Honduvilla N; Cifuentes A; Ortega MA; Pastor M; Gainza G; Gainza E; Buján J; Álvarez-Mon M Endocr Connect; 2018 Apr; 7(4):584-594. PubMed ID: 29592858 [TBL] [Abstract][Full Text] [Related]
52. Controlled drug release for tissue engineering. Rambhia KJ; Ma PX J Control Release; 2015 Dec; 219():119-128. PubMed ID: 26325405 [TBL] [Abstract][Full Text] [Related]